Propranolol Trial for Aggression and Self-Injury in People with Autism
Phase 2
60
about 3.1 years
12–40
2 sites in NY
What this study is about
This trial is testing if propranolol can help reduce aggression, self-injury, and severe disruptive behaviors in people with autism. Participants will receive either propranolol or a placebo daily for 12 weeks. After the initial period, some participants may continue receiving propranolol for another 12 weeks.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Placebo
- 2.Take Propranolol
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
propranolol (Non-selective beta blocker; slows heart rate)
Primary: Incidence of safety concerns and side effects associated with high-dose propranolol, including changes in blood pressure, pulse, and occurrence of dysrhythmias.
Psychiatry / Mental Health